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To catheterize the CS, a sheath isused in first intention in 81%. CS angi-
ography is performed in 90%, with an inflated balloon in 59%.
In case of atrial fibrillation withCHA2DS2-vasc<2, 38% implant without
VKA interruption, 57% stop VKA without substitution, and unfractionned
heparin (UH) or low weight heparin (LWH) substitution is chosen in 5%, vs
respectively 69% and 11% and 19% if CHA2DS2-vasc >4. 
Conclusion: Most of implantations are performed under local anesthesia. Left
sided is prefered, especially in case of CRT-D implantation. Most physicians com-
bine the venous accesses, start with the RV septal lead, and perform a CS angio-
gram via an inflated balloon. In AF patient, VKA interruption is preferred in low
risk patients but not in high risk ones. Few implanters choose VKA substitution.
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Routine face-profile fluoroscopic screening may be useful for earlier
detection, monitoring and management of externalized conductors in
patients implanted with Riata leads
Maciej Kubala, S Traullé, Jean-Sylvain Hermida
CHU Amiens, rythmologie, Amiens, France
Increased rates of structural abnormalities have been reported in the Riata
family of implantable cardioverter-defibrillator (ICD) leads. The reliability of
defibrillation leads with insulation damage, or abraded cables that are not
immediate cause of failure is unknown. The incidence of these defects can be
underestimated due to the absence of abnormal electrical parameters detected
by regular ICD interrogation. Little is known about the time lag for emergence
of functional abnormalities in such leads.
Methods: Forty eight patients who received small-caliber leads of the
Riata family (models 1570, 1572, 1580, 1582, 7000, 7002) in our institution
between May 2002 and March 2008 were systematically called for an addi-
tional visit including face-profile thoracic fluoroscopy to ascertain integrity of
the leads followed by routinely repeated fluoroscopies at every six-month
visits. We assessed the prevalence of insulation defects with externalized
cables and their relation with adverse events requiring lead revision. We tried
to evaluate the time lag for emergence of their electrical dysfunction.
Results: Thirty five patients, mean age=64±10 years, with at least 7-month
completed fluoroscopy follow-up were included in analysis. After 55-month
mean follow-up, 57% of patients completed 2 or more spaced fluoroscopies.
Externalized conductors were identified in 7 (20%) patients after a 48-months
(12-114) mean delay and in 4 (11%) cases the images were classified as border-
line. Three of 7 patients with insulation damage required lead replacement for the
reason of clinical adverse events. In two other patients an increase of abrasion
was observed on repeated fluoroscopy without changes in electrical parameters.
Conclusion: Insulation damage with externalized conductors was identi-
fied in 20% of patients implanted with Riata leads. Routine fluoroscopic
screening allowed earlier detection of these defects and may be useful for their
closer monitoring and better management.
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Introduction: Both type 1 Myotonic Dystrophy (Steinert disease) and Bru-
gada syndrome may be complicated by conduction disturbances and sudden
death. ST elevation in the right precordial leads is the hallmark of Brugada
syndrome but may be seen in some myopathies. Mutations in DMPK gene in
Steinert pts may lead to cytosolic accumulation of muted toxic RNA or altered
alternate splicing of some RNA potentially causing sodium channel dysfunc-
tions. The prevalence of Brugada ECG pattern in Steinert disease is unknown.
Methods: we perform ajmaline challenge test (1 mg/kg over 5 min) during
electrophysiological (EP) testing in a population of 44 Steinert disease pts
(27 men, 41±15 years old) without ST elevation at baseline. Left ventricular
EF was normal in each case. The presence of type 1 ST elevation (> 2 mm J
elevation with coved ST and negative T wave) after ajmaline challenge was
correlated to clinical, ECG and electrophysiological variables.
Results: 8 pts (18%) present type 1 ST elevation in the right precordial
leads after ajmaline infusion. Brugada pattern was more often seen in men:
7/27 (26%) vs 1/17 (6%) (p=0.09). Patients with negative ajmaline test pre-
sented more often with fascicular block: 13/35 (27%) versus none (p=0.03).
Brugada pattern was not correlated to age, symptoms, PR interval, QRS,
QT or QTc durations, HV interval (at baseline or after ajmaline), presence of
bundle branch block, of late potentials at SA-ECG or inducibility of ventric-
ular arrhythmias at EP study.
Nine pts were implanted with a pace maker and four with an ICD. Signi-
ficant or symptomatic bradycardia did not happen in any non implanted pts,
while only one pt presented with malignant ventricular arrhythmias during the
6.3±2.6 years follow-up (ventricular fibrillation with hypokaliemia in an ajma-
line negative pt).
Conclusion: Brugada ECG pattern can be elicited by class 1 drug in 18%
of Steinert disease pts and especially in men. Presence of type 1 ST elevation
under class 1 drug in Steinert disease do not seem to have some significant
clinical or ECG correlations.
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A simple method to implant epicardial AICD using two separated coils
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Purpose: Surgical epicardial AICD implantation has been quite abandoned
since developpement of endocardial leads and decrease in AICD size. Epicar-
dial patches did not improve since 30 years, are rigid and need to be sewed to
the epicard which favors bleeding. In some rare cases, epicardial AICD implan-
tation remains indicated. Therefore we tested a new simple implant technique
in 5 patients undergoing open chest surgery trough a median sternotomy.
Methods: In 3 cases surgery was performed for percutaneous infected lead
extraction failure. The two other patients required surgical operation and
AICD implant (one for mitral valve regurgitation, one for tricuspid repair). A
screw-in bipolar pace/sense lead (St Jude MyodexTM 1084T) was placed on
the right ventricular free wall and two defibrillation leads (Medtronic Trans-
vene®6937) were respectively sewed on the pulmonary artery trunk and on
the diaphragmatic wall of the right ventricle and then connected to an AICD
(Biotronik Lumax 540) placed in an abdominal pocket.
Results: Best defibrillation configuration (31 J tested) was obtained with a
shock delivered between the two coils (AICD passive), from the inferior one
to the superior one. There were no major cardiovascular complications.
Clinical and telemonitoring follow up (mean 10 months) showed stable ven-
tricular stimulation and detection thresholds as well as lead and coil impe-
dances. No arrhythmias occurred.
Conclusions: Epicardial AICD implantation is feasible in a simple way.
Long term follow up is needed to confirm post operative results.
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Material and methods: We carried out a multicenter survey in 8 French
centers. Each patient received a questionnaire to evaluate his perceptions on
information and consent, risks associated with pacemaker implantation and
ability to perform various routine activities.
Results: We included 185 patients. The mean age was 75.4 + 10.5 years.
A large number of patients considered many routine activities as unsafe,
such as sleeping on the side of the pacemaker (12%), swimming (15%),
driving automobiles (17%) and passing through metal detectors (47%).
Patients had also misconceptions about using induction hobs (38%) and arc
welding equipment (32%). 
As regards medical imaging, 38% did not know if they could undergo MRI
exams. As regards medical follow up, 11% of patients thought they did not
need heart medications and 17% that they were exempt from monitoring by a
cardiologist. In univariate analysis, the factors associated to misconceptions
about pacemakers were an age above 75 years and a primary implantation.
Conclusion: The results of our study highlight patients’ misperceptions on
life with a pacemaker. This should lead cardiologists to better inform patients
at the time of pacemaker implantation.
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Long-term follow-up after implantable loop recorder in patients with
syncope: results of a french Survey
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Hôpital le Rainy-Montfermeil, Montfermeil, France
Background and objective: Despite recent advances in diagnostic proce-
dures, syncope remains unexplained in 15 to 35% of patients. If implantable
loop recorder is a validated diagnostic tool for unexplained syncope, results of
this strategy are largely issued from randomized studies. We lack the results
of surveys. The aim of this study was to report a single center experience with
implantable loop recorder, in patients with unexplained syncope.
Methods and results: A device (Medtronic Reveal) was implanted in
30 patients between january 2009 and january 2012. 80% of patients experi-
enced recurrent syncope and 20% were implanted after a first syncope with a
suspicion of an arrhythmic cause. During a mean follow-up of 10.5±8.5
months after device implantation, loop recording definitively determined that
an arrhythmia was the cause of symptoms in 9 patients (30%). 
Thirteen patients (41%) experienced syncope or pre-syncope. In 6 of the
13 patients with syncope during follow-up no diagnosis could be made (non
arrhythmic causes- one patient has been diagnosed as presenting epilepsy and
5 as having hypotensive vasovagal syncope). In 7 patients, the ILR lead to the
diagnostic showing an arrhythmic etiology. Two other patients presented an
abnormal ILR results without symptoms.
Diagnosis included sinusal arrest in 3 patients, bradycardia in 1 patient,
advanced atrio-ventricular block in 3 patients and ventricular arrythmia in
2 patients. Therapy was instituted in all patients, in whom an arrhythmic cause
was found except one who refused the therapy (6 pacemaker and 2 implant-
able cardioverter defibrillator implantation).
Conclusion: In this registry, implantable loop recorder implantation led to
the diagnosis of an arrhythmic cause in 30% of patients. This percentage
seems to be lower than those reported in randomized studies. These results
should be confirmed in a larger multicentric survey.
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Introduction: We developed the usage of a simple tunnelling method from
controlateral access to the device in case of homolatéral subclavian access
failure when an additional lead is needed.
Goal of the study: long term evaluation of feasibility and safety of this
tunneling strategy.
Method: From September 1998 to September 2011, a coronary sinus (CS)
lead was implanted through controlateral access after failure of homolateral to
the device implantation in 31 consecutive patients (19 males 72+/- 8 yo). Indi-
cations were thrombosis 14 and failure to catheterize CS 17. All these patients
were already implanted with a single or double chamber pacemaker or internal
cardiac defibrillator and were referred for upgrading to biventricular pacing.
The packaging sheath of a simple conventional catheter (plastimed) was intro-
duced from one side to the other under local anesthesia after scissors dissec-
tion under local anesthesia. Tunneling of coronary sinus lead was performed
through the sheath which was then withdrawed.
Results: Success tunneling procédure rate was 100%.Tunelling time was
3+/-2 mn. Complications related to the procedure: 2 cases of xylocaine over-
dose needed temporary ventilation assistance at beginning of experience. 1
early dislodgment needed replacement, 2 cases of early battery wear because
of low impédance of the cs lead. No hematoma, no acute or late pain com-
plain, no lead infection were reported.
Conclusion: Controlateral implantation through a simple packaging sheath
is a simple and safe option in case of homolateral access failure in upgrading
indications.
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Introduction: early repolarization (ER) in Brugada or short QT syndrome
is common and has been associated to a less favourable outcome. Even if
apparently paradoxical, ER can also be seen in long QT (LQT) but prevalence
and correlations to other variables are unknown.
Methods: 12 lead ECG of 37 LQT pts (19 men, 39±21 yo) and 80 matched
controls were reviewed. LQT pts were selected by a positive genetic testing
(n=27) or by showing abnormal T wave and long QT interval (n=10) either
spontaneously or during epinephrin infusion. ER was defined by >1 mm J
point elevation in the inferior or lateral leads with notch or slurring pattern.
Presence of ER was correlated to the clinical and ECG characteristics and
results genetic analysis.
Results: QT was 409±53 msec in pts and 372±24 in controls (p<0.0001)
(QTc 476±52 vs 392±26 msec, p<0.0001). Two LQT pts presented with resus-
citated sudden death and 4 with syncope at the time of diagnosis.
14/37 LQT pts (38%) had ER compared to 17/80 (21%) controls (p=0.05). 
ER was more frequent in men (12/19, 63%) compared to women (2/18,
11%) (p=0.001) but was not correlated to age. Pts with ER had slower heart
rate (63±10 vs 75±18 bpm, p=0.02).
ER was not correlated to symptoms or cardiac events (no ER in the 2 pts
with SD and in 2/4 pts with syncope).
QT were longer in pts with ER (450±68 vs 397±54 msec in V2, p=0.01)
but there was no correlations between ER and corrected QT intervals.
ER was more often seen in pts with or without mutations although non
significantly (8/27 vs 6/10, p=0.09), but there was a trend toward more fre-
quent ER in case of HeRG mutations (6/12) than KCNQ1 or KCNJ2 muta-
tions (2/11 and 0/4) (p=0.09).
Conclusion: ER is very common in LQT pts and is related to the gender
and to the heart rate but not to the corrected QT duration. ER does not seem
to be correlated to cardiac events in this series but may be linked to some gene
mutations. Further studies are needed for demonstrating additional mutations/
variants or the existence of an early transient voltage gradient due to altered
kinetics in muted potassium channels with loss of function.
